Search Results

There are 7427719 results for: content related to: Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis C

  1. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  2. You have free access to this content
    New HCV therapies on the horizon

    Clinical Microbiology and Infection

    Volume 17, Issue 2, February 2011, Pages: 122–134, J. Vermehren and C. Sarrazin

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1469-0691.2010.03430.x

  3. You have full text access to this OnlineOpen article
    Expert opinion on the treatment of patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 16, Issue 2, February 2009, Pages: 75–90, S. Zeuzem, T. Berg, B. Moeller, H. Hinrichsen, S. Mauss, H. Wedemeyer, C. Sarrazin, D. Hueppe, E. Zehnter and M. P. Manns

    Version of Record online : 28 AUG 2008, DOI: 10.1111/j.1365-2893.2008.01012.x

  4. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  5. You have full text access to this OnlineOpen article
    Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 94–102, N. Reau, F. M. Hamzeh, E. Lentz, X. Zhou and D. Jensen

    Version of Record online : 12 JAN 2011, DOI: 10.1111/j.1365-2893.2010.01422.x

  6. You have free access to this content
    Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 9, May 2010, Pages: 1018–1027, Y. ROTMAN, B. B. BORG, A. SOZA, J. J. FELD, A. A. MODI, R. LOOMBA, G. LUTCHMAN, E. RIVERA, E. DOO, M. G. GHANY, T. HELLER, A. U. NEUMANN, T. J. LIANG and J. H. HOOFNAGLE

    Version of Record online : 16 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04263.x

  7. Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response

    Journal of Viral Hepatitis

    Volume 19, Issue 5, May 2012, Pages: 332–340, P. J. Clark, A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, S. A. Harrison, T. J. Urban, S. Naggie, J. Fellay, H. L. Tillmann, K. Shianna, S. Noviello, L. D. Pedicone, R. Esteban, P. Kwo, M. S. Sulkowski, N. Afdhal, J. K. Albrecht, D. B. Goldstein, J. G. McHutchison, A. J. Muir and for the IDEAL investigators

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1365-2893.2011.01553.x

  8. You have free access to this content
    Clinical trial: extended treatment duration of peginterferon-alpha2b plus ribavirin for 72 and 96 weeks in hepatitis C genotype 1-infected late responders

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 4, August 2009, Pages: 343–351, M. NAGAKI, M. SHIMIZU, J. I. SUGIHARA, E. TOMITA, C. SANO, T. NAIKI, K. KIMURA, K. AMANO, T. SAKAI, M. NINOMIYA, T. KOJIMA, N. KATSUMURA, M. FUJIMOTO and H. MORIWAKI

    Version of Record online : 26 MAY 2009, DOI: 10.1111/j.1365-2036.2009.04048.x

  9. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents

    Journal of Viral Hepatitis

    Volume 19, Issue 7, July 2012, Pages: 449–464, F. Poordad and D. Dieterich

    Version of Record online : 7 JUN 2012, DOI: 10.1111/j.1365-2893.2012.01617.x

  10. Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s1, January 2012, Pages: 37–41, M. Rumi, A. Aghemo and G. M. Prati

    Version of Record online : 10 JAN 2012, DOI: 10.1111/j.1365-2893.2011.01525.x

  11. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  12. You have free access to this content
    Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV – the role of epoetin, G-CSF and novel agents

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 9, May 2010, Pages: 929–937, R. MAC NICHOLAS and S. NORRIS

    Version of Record online : 18 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04269.x

  13. Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study

    Journal of Viral Hepatitis

    Volume 18, Issue 6, June 2011, Pages: 393–399, C. Puoti, G. Barbarini, A. Picardi, M. Romano, A. Pellicelli, A. Barlattani, F. Mecenate, R. Guarisco, O. M. Costanza, L. Spilabotti, L. Bellis, M. E. Bonaventura, O. Dell’ Unto, M. G. Elmo, A. M. Nicolini, L. Nosotti, F. Soccorsi and on behalf of the Club Epatologico Ospedaliero (Hospital Liver Club, CLEO)

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1365-2893.2010.01319.x

  14. Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study

    Journal of Viral Hepatitis

    Volume 17, Issue 7, July 2010, Pages: 459–468, T. Witthoeft, D. Hueppe, C. John, J. Goelz, R. Heyne, B. Moeller, G. Teuber, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, G. Moog, N. Dikopoulos and S. Mauss

    Version of Record online : 11 FEB 2010, DOI: 10.1111/j.1365-2893.2009.01255.x

  15. Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations

    Journal of Viral Hepatitis

    Volume 19, Issue 4, April 2012, Pages: 236–243, I. M. Jacobson, F. Poordad, R. S. Brown Jr, P. Y. Kwo, K. R. Reddy and E. Schiff

    Version of Record online : 2 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01552.x

  16. Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy

    Journal of Viral Hepatitis

    Volume 16, Issue 12, December 2009, Pages: 867–875, J. E. Arends, J. Cohen Stuart, L. C. Baak, M. E. Van Der Ende, K. J. Van Erpecum, C. P. M. Simons, G. J. Boland, D. Van Baarle and A. I. M. Hoepelman

    Version of Record online : 11 MAY 2009, DOI: 10.1111/j.1365-2893.2009.01143.x

  17. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  18. Hepatitis C therapy in non-genotype 1 patients: the near future

    Journal of Viral Hepatitis

    Volume 19, Issue 8, August 2012, Pages: 525–536, C. Wartelle-Bladou, G. Le Folgoc, M. Bourlière and L. Lecomte

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2893.2012.01634.x

  19. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Version of Record online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  20. Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 77–87, F. Stickel, B. Helbling, M. Heim, A. Geier, C. Hirschi, B. Terziroli, K. Wehr, A. De Gottardi, F. Negro and T. Gerlach

    Version of Record online : 18 OCT 2011, DOI: 10.1111/j.1365-2893.2011.01527.x